AnteoTech Ltd (ADO) AI Stock Analysis

• Market Cap: AU$60.00M
• Dividend Yield: N/A
• Average Volume (3M): 3.22M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.83
• Revenue Growth: 110.44%
• EPS Growth: 35.90%
• Country: AU
• Employees: 24
• Sector: Healthcare
• Sector Strength: 45
• Industry: Biotechnology
• EPS (TTM): >-0.01
• Shares Outstanding: 2,727,438,700
• 10 Day Avg. Volume: 1,304,138
• 30 Day Avg. Volume: 3,215,646
• PEG Ratio: 0.14
• Price to Book (P/B): 10.79
• Price to Sales (P/S): 35.07
• P/FCF Ratio: -5.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 42 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

AnteoTech Ltd's overall stock score is primarily impacted by its weak financial performance, characterized by ongoing losses and cash flow challenges. While technical analysis shows some short-term bullish momentum, the high RSI suggests potential overbought conditions. Valuation metrics further highlight profitability issues, with a negative P/E ratio and no dividend yield.

AnteoTech Ltd Business Overview & Revenue Model

Company Description

AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

How the Company Makes Money

AnteoTech Ltd generates revenue primarily through the commercialization of its AnteoBind technology. The company licenses this technology to partners and clients in various industries who integrate it into their product offerings, particularly in the fields of diagnostics and energy storage. Revenue streams include licensing fees, royalties from product sales that utilize AnteoBind, and direct sales of products incorporating the technology. Additionally, AnteoTech has formed strategic partnerships and collaborations that enhance its market reach and contribute to its earnings. These partnerships often involve joint development agreements or co-marketing efforts that bolster the company's presence in target markets.

AnteoTech Ltd Financial Statement Overview

Summary

AnteoTech Ltd faces significant financial challenges, with ongoing losses and revenue volatility. The income statement shows negative net profit margins and operational inefficiencies. The balance sheet indicates moderate leverage but poor returns on equity, and cash flow issues persist with negative operating and free cash flows.

Income Statement

AnteoTech Ltd has experienced significant revenue volatility, with a notable decline in revenue growth rate of -277.78% in the most recent period. The company consistently reports negative net profit margins, with the latest at -6.98%, indicating ongoing profitability challenges. The EBIT and EBITDA margins are also negative, reflecting operational inefficiencies. Despite a high gross profit margin, the overall income statement performance is weak due to persistent losses.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio of 0.62, suggesting manageable leverage. However, the return on equity is negative at -2.15%, indicating that the company is not generating returns on shareholder investments. The equity ratio is not explicitly calculated, but the declining stockholders' equity over time suggests weakening financial stability.

Cash Flow

AnteoTech Ltd's cash flow statement reveals negative operating and free cash flows, with a slight improvement in free cash flow growth rate at -12.83%. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is slightly above 1, indicating that free cash flow is somewhat aligned with net income, but overall cash flow performance remains weak.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	-545.00K	968.88K	460.40K	365.72K	760.88K	898.07K
Gross Profit	-545.00K	968.88K	460.40K	365.72K	760.88K	898.07K
EBITDA	-8.00M	-7.96M	-11.57M	-12.35M	-12.07M	-7.18M
Net Income	-8.72M	-6.76M	-8.88M	-12.65M	-10.72M	-6.22M
Balance Sheet
Total Assets	11.54M	6.45M	9.38M	5.36M	15.26M	23.68M
Cash, Cash Equivalents and Short-Term Investments	7.38M	2.34M	5.03M	2.72M	10.10M	21.39M
Total Debt	2.27M	1.96M	2.31M	1.31M	1.03M	1.28M
Total Liabilities	3.84M	3.30M	4.08M	2.99M	2.91M	2.56M
Stockholders Equity	7.70M	3.15M	5.31M	2.38M	12.36M	21.11M
Cash Flow
Free Cash Flow	-6.94M	-6.05M	-7.58M	-8.77M	-11.77M	-4.76M
Operating Cash Flow	-6.32M	-5.83M	-6.52M	-8.08M	-8.65M	-4.55M
Investing Cash Flow	-570.63K	-174.87K	-1.06M	-690.83K	-3.12M	-213.07K
Financing Cash Flow	9.63M	3.32M	9.89M	1.39M	482.29K	22.94M

AnteoTech Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ADO, the sentiment is Positive. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 92.13 is Negative, neither overbought nor oversold. The STOCH value of -100.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ADO.

AnteoTech Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PTX	56 Neutral	44.16M	-4.62	0.00%	―	0.00%	10.78%
SPL	55 Neutral	54.37M	-5.42	0.00%	―	-40.74%	-21.21%
AVE	46 Neutral	20.63M	―	0.00%	―	306.88%	0.00%
PIQ	46 Neutral	57.29M	-5.79	-61.61%	―	7.65%	-19.13%
CYP	43 Neutral	46.30M	-4.31	0.00%	―	0.00%	16.61%
ADO	42 Neutral	AU$60.00M	―	-159.86%	―	110.44%	35.90%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

AnteoTech Ltd Corporate Events

AnteoTech Issues Shares Under Equity Incentive Plan

AnteoTech Ltd announced the issuance of 22,138,295 fully paid ordinary shares to staff as part of its Equity Incentive Plan for FY2025 performance outcomes. This move, compliant with the Corporations Act, reflects the company’s commitment to rewarding its employees and potentially strengthens its market position by aligning staff interests with corporate growth. The issuance is expected to have implications for stakeholders by potentially enhancing employee motivation and retention, thereby supporting the company’s operational and strategic goals.

AnteoTech Ltd Announces Quotation of New Securities on ASX

AnteoTech Ltd has announced the quotation of 22,138,295 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code ADO, effective from August 28, 2025. This move is part of a previously announced transaction, and it is expected to impact the company’s financial operations by potentially increasing liquidity and market visibility, which could influence investor interest and stakeholder engagement.

AnteoTech Ltd Releases Full Year Results and Business Update

AnteoTech Ltd has released its Full Year Results and Business Update, accompanied by a presentation and a live webinar hosted by the CEO, Merrill Gray. The announcement highlights the company’s ongoing commitment to addressing the growing demand for advanced material solutions in the global battery market and life sciences sector. This update is significant for stakeholders as it underscores AnteoTech’s strategic focus on innovation and sustainability, potentially impacting its market positioning positively.

AnteoTech Releases 2024 Corporate Governance Statement

AnteoTech Ltd has released its 2024 Corporate Governance Statement and Appendix 4G, as per ASX listing rules. This announcement, authorized by the company’s board, underscores AnteoTech’s commitment to transparency and regulatory compliance, which could enhance its reputation and trust among stakeholders in the advanced materials and life sciences sectors.

AnteoTech Ltd Releases FY2025 Annual Report Highlighting Strategic Advances

AnteoTech Ltd has released its FY2025 Annual Report, detailing its financial results for the year ending June 30, 2025. The report, authorized by the company’s board, highlights the company’s ongoing commitment to providing advanced material solutions in the battery and life sciences markets. This announcement underscores AnteoTech’s strategic focus on innovation and sustainability, potentially strengthening its position in the global market and offering implications for stakeholders interested in high-performance, cost-effective materials.

AnteoTech Ltd Announces Cessation of Securities

AnteoTech Ltd announced the cessation of 3,750,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth prospects.

AnteoTech Ltd Announces Proposed Issue of Securities

AnteoTech Ltd has announced a proposed issue of 22,150,000 ordinary fully paid securities, with an expected issue date of August 29, 2025. This move is part of a placement or other type of issue, as disclosed to the ASX. The announcement could potentially impact the company’s operations by increasing its capital base, which may enhance its market positioning and provide additional resources for strategic initiatives.

AnteoTech Appoints New MD & CEO and Completes Staff Performance Review

AnteoTech Ltd has appointed Ms. Merrill Gray as the new Managing Director and Chief Executive Officer, effective August 19, 2025. Ms. Gray, who has been serving as the Interim MD & CEO, brings extensive experience in science, engineering, and business leadership, with a strong track record in commercializing advanced technologies. Her appointment is expected to enhance the company’s strategic focus and drive growth in product sales and shareholder value. Additionally, AnteoTech has completed its annual staff performance review, resulting in the issuance of approximately 22,150,000 ordinary shares to employees under the Short-Term Incentive Program, aimed at preserving cash resources and incentivizing employees to create shareholder value.

AnteoTech Opts Out of Queensland Grant to Focus on Cost-Effective Commercialization

AnteoTech Ltd has decided not to proceed with a A$1.4 million grant from the Queensland Government under the Queensland Critical Minerals and Battery Technology Fund, as it would require an additional A$2.2 million investment from the company. Instead, AnteoTech has established cost-effective alternatives for commercial cell design performance testing, allowing it to focus resources on commercializing its market-ready products. This decision is expected to save the company approximately A$2.2 million in net cash flow and does not affect its eligibility for a separate A$4 million grant from the Australian Renewables Energy Agency.